WDB coco Co Ltd
TSE:7079
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
WDB coco Co Ltd
Capital Expenditures
WDB coco Co Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
WDB coco Co Ltd
TSE:7079
|
Capital Expenditures
-¥15.7m
|
CAGR 3-Years
28%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Carna Biosciences Inc
TSE:4572
|
Capital Expenditures
-¥9.3m
|
CAGR 3-Years
58%
|
CAGR 5-Years
33%
|
CAGR 10-Years
-12%
|
|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Capital Expenditures
-¥6.5B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-13%
|
|
|
Medinet Co Ltd
TSE:2370
|
Capital Expenditures
-¥32.4m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
29%
|
|
|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
Capital Expenditures
-¥53.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
|
|
D
|
DNA Chip Research Inc
TSE:2397
|
Capital Expenditures
-¥58.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-14%
|
|
WDB coco Co Ltd
Glance View
WDB coco Co., Ltd. engages in the safety information management business. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 403 full-time employees. The company went IPO on 2019-12-25. The firm is engaged in the provision of safety information management service as an agent and support for drug development, document support service, development support service and clinical development support service. The safety information management service provides support services such as input, evaluation drafting and report drafting. The document support service provides support services from QC (quality assurance) and translation of documents and materials necessary for marketing approval to PMDA (Pharmaceuticals and Medical Devices Agency) to the creation of approval application called CTD (Common Technical Document). The development support service provides services such as survey form management, filing of survey-related documents and call center operations. The clinical development support service provides support services for clinical trial related work.
See Also
What is WDB coco Co Ltd's Capital Expenditures?
Capital Expenditures
-15.7m
JPY
Based on the financial report for Mar 31, 2025, WDB coco Co Ltd's Capital Expenditures amounts to -15.7m JPY.
What is WDB coco Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
16%
Over the last year, the Capital Expenditures growth was 82%. The average annual Capital Expenditures growth rates for WDB coco Co Ltd have been 28% over the past three years , 16% over the past five years .
